Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Gasperoni

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of the American Statistical Association|June 7, 2023
Score-Driven Modeling of Spatio-Temporal DataFrancesca Gasperoni, Alessandra Luati, Lucia Paci, et al.
Pharmaceutical Statistics|May 6, 2024
Visualizing hypothesis tests in survival analysis under anticipated delayed effectsJosé L Jiménez, Isobel Barrott, Francesca Gasperoni, et al.
BMC Health Services Research|June 14, 2020
Evaluating the effect of healthcare providers on the clinical path of heart failure patients through a semi-Markov, multi-state modelFrancesca Gasperoni, Francesca Ieva, Anna Maria Paganoni, et al.
Biostatistics (Oxford, England)|December 28, 2018
Non-parametric frailty Cox models for hierarchical time-to-event dataFrancesca Gasperoni, Francesca Ieva, Anna Maria Paganoni, et al.
Plos One|June 8, 2017
Multi-state modelling of heart failure care path: A population-based investigation from ItalyFrancesca Gasperoni, Francesca Ieva, Giulia Barbati, et al.
Journal of the Royal Statistical Society. Series A, (Statistics in Society)|July 15, 2025
Optimal risk-assessment scheduling for primary prevention of cardiovascular diseaseFrancesca Gasperoni, Christopher H Jackson, Angela M Wood, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 25, 2019
Adherence to Disease-Modifying Therapy in Patients Hospitalized for HF: Findings from a Community-Based StudyMarta Spreafico, Francesca Gasperoni, Giulia Barbati, et al.
BMJ Public Health|April 1, 2025
Optimal risk assessment intervals for primary prevention of cardiovascular disease: a population-based two-stage landmarking studyZander Gu, Francesca Gasperoni, Ellie Paige, et al.
The Journal of Urology|October 2, 2017
Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume CenterNicola Nicolai, Nicholas Tarabelloni, Francesca Gasperoni, et al.
The British Journal of Dermatology|November 29, 2024
Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trialAlexa B Kimball, Falk G Bechara, Aysha Badat, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of the American Statistical Association|June 7, 2023
Score-Driven Modeling of Spatio-Temporal DataFrancesca Gasperoni, Alessandra Luati, Lucia Paci, et al.
Pharmaceutical Statistics|May 6, 2024
Visualizing hypothesis tests in survival analysis under anticipated delayed effectsJosé L Jiménez, Isobel Barrott, Francesca Gasperoni, et al.
BMC Health Services Research|June 14, 2020
Evaluating the effect of healthcare providers on the clinical path of heart failure patients through a semi-Markov, multi-state modelFrancesca Gasperoni, Francesca Ieva, Anna Maria Paganoni, et al.
Biostatistics (Oxford, England)|December 28, 2018
Non-parametric frailty Cox models for hierarchical time-to-event dataFrancesca Gasperoni, Francesca Ieva, Anna Maria Paganoni, et al.
Plos One|June 8, 2017
Multi-state modelling of heart failure care path: A population-based investigation from ItalyFrancesca Gasperoni, Francesca Ieva, Giulia Barbati, et al.
Journal of the Royal Statistical Society. Series A, (Statistics in Society)|July 15, 2025
Optimal risk-assessment scheduling for primary prevention of cardiovascular diseaseFrancesca Gasperoni, Christopher H Jackson, Angela M Wood, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 25, 2019
Adherence to Disease-Modifying Therapy in Patients Hospitalized for HF: Findings from a Community-Based StudyMarta Spreafico, Francesca Gasperoni, Giulia Barbati, et al.
BMJ Public Health|April 1, 2025
Optimal risk assessment intervals for primary prevention of cardiovascular disease: a population-based two-stage landmarking studyZander Gu, Francesca Gasperoni, Ellie Paige, et al.
The Journal of Urology|October 2, 2017
Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume CenterNicola Nicolai, Nicholas Tarabelloni, Francesca Gasperoni, et al.
The British Journal of Dermatology|November 29, 2024
Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trialAlexa B Kimball, Falk G Bechara, Aysha Badat, et al.
Pageof 2